Benitec Announces Positive In Vitro Data from Muscular Dystrophy Program
December 06, 2012
Benitec Announces Positive In Vitro Data from Muscular Dystrophy Program
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- UniQure Enters RNAi Field with Benitec Cross-Licensing Deal
December 6, 2012 / Gene Silencing News - People in the News: Robert Wassman, Dganit Bar, David Suhy
October 11, 2012 / Gene Silencing News - Genable Secures License to Benitec RNAi Technology as It Eyes Rare Ocular Disease
July 19, 2012 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to City of Hope; Merck; Benitec; and More
December 15, 2011 / Gene Silencing News - Benitec Adds Rare Form of Muscular Dystrophy to Pipeline, Seeks Collaboration for Pain Program
November 3, 2011 / Gene Silencing News